BSX vs. IHI

In the year-to-date period, BSX achieves a 17.40% return, which is significantly higher than IHI's 6.63% return. Over the past 10 years, BSX has outperformed IHI with an annualized return of 19.28%, while IHI has yielded a comparatively lower 12.54% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BSX Sharpe Ratio is 1.85, which is higher than the IHI Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of BSX and IHI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BSX has not paid dividends to shareholders, while IHI's dividend yield for the trailing twelve months is around 0.44%.

The maximum BSX drawdown since its inception was -89.15%, which is greater than IHI's maximum drawdown of -49.64%. Use the drawdown chart below to compare losses from any high point for BSX and IHI. For additional features, visit the drawdowns tool.

Boston Scientific Corporation (BSX) has a higher volatility of 5.80% compared to iShares U.S. Medical Devices ETF (IHI) at 4.99%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.